FindTrial
Sign In

Ondansetron and Noradrenalin for prevention and treatment of spinal hypotension during caesarean section. A comparison of intermittent bolus infusion versus continuous syringe pump administration in combination with 5-HT3-receptor antagonists.

Ondansetron and Noradrenalin for prevention and treatment of spinal hypotension during caesarean section. A comparison of intermittent bolus infusion versus continuous syringe pump administration in combination with 5-HT3-receptor antagonists.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00041092
Enrollment
500
Registered
2026-07-27
Start date
2024-02-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I97

Interventions

Group 1: Patients treated with intermittent bolus doses of norepinephrine who also received 4 mg of ondansetron preoperatively. Blood pressure readings are recorded at standardized time points during

Sponsors

Klinikum Bremen Mitte, Klinik für Anästhesiologie und Schmerztherapie
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Pregnancy, Delivery via cesarean section

Exclusion criteria

Exclusion criteria: No consent of mother after providing information of scope and nature of the study

Design outcomes

Primary

MeasureTime frame
Primary Endpoint: Maternal blood pressure levels The Blood Pressure values are routinely measured and documented during the course of the operation.—

Secondary

MeasureTime frame
Newborn outcome: APGAR, umbilical pH and Base excess The values are routinely measured and documented after the birth of the child.—

Countries

Germany

Contacts

Public ContactMichael Winterhalter

Klinikum Bremen Mitte

michael.winterhalter@gesundheitnord.de+49 0421 497 73402

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 10, 2026